XOMA (NASDAQ:XOMAO – Get Free Report) will likely be releasing its results before the market opens on Thursday, April 30th. Analysts expect XOMA to post earnings of $0.1575 per share and revenue of $13.7310 million for the quarter.
XOMA Price Performance
Shares of NASDAQ:XOMAO opened at $25.52 on Thursday. The company’s fifty day moving average price is $25.50 and its 200-day moving average price is $25.43. XOMA has a one year low of $24.86 and a one year high of $26.40.
XOMA Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Thursday, April 2nd were issued a dividend of $0.5234 per share. The ex-dividend date of this dividend was Thursday, April 2nd. This represents a $2.09 annualized dividend and a dividend yield of 8.2%.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Read More
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
